| Literature DB >> 30597328 |
Nishad Thamban Chandrika1, Emily K Dennis1, Sanjib K Shrestha1, Huy X Ngo1, Keith D Green1, Stefan Kwiatkowski2, Agripina Gabriela Deaciuc1, Linda P Dwoskin1, David S Watt3, Sylvie Garneau-Tsodikova4.
Abstract
N,N'-Diaryl-bishydrazones of [1,1'-biphenyl]-3,4'-dicarboxaldehyde, [1,1'-biphenyl]-4,4'-dicarboxaldehyde, and 4,4'-bisacetyl-1,1-biphenyl exhibited excellent antifungal activity against a broad spectrum of filamentous and non-filamentous fungi. These N,N'-diaryl-bishydrazones displayed no antibacterial activity in contrast to previously reported N,N'-diamidino-bishydrazones and N-amidino-N'-aryl-bishydrazones. The leading candidate, 4,4'-bis((E)-1-(2-(4-fluorophenyl)hydrazono)ethyl)-1,1'-biphenyl, displayed less hemolysis of murine red blood cells at concentrations at or below that of a control antifungal agent (voriconazole), was fungistatic in a time-kill study, and possessed no mammalian cytotoxicity and no toxicity with respect to hERG inhibition.Entities:
Keywords: Aspergillus sp.; Candida albicans; Cytotoxicity; Hemolysis; Non-albicans Candida; hERG channel
Mesh:
Substances:
Year: 2018 PMID: 30597328 PMCID: PMC6351225 DOI: 10.1016/j.ejmech.2018.12.042
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514